aidsmap news story
Resistance to dolutegravir was seen in 8% of people with repeatedly detectable viral loads who had resistance test results in an ongoing study in Lesotho. Compared to previous rates of dolutegravir resistance in the same cohort from three years ago, there was no increase. Most people with dolutegravir resistance also had resistance to other HIV drugs that it is often combined with.
The findings from Dr Anna Klicpera and colleagues were presented by Professor Niklaus Labhardt of University Hospital Basel at HIV Glasgow 2026.
Read the full news story here.
View all aidsmap reports from HIV Glasgow 2026
Source : aidsmap
Related HIV and Co-Infections News
-
[HIV Glasgow 2026] aidsmap | European guidelines widen access to two-drug HIV treatment
-
[HIV Glasgow 2026] Infectious Disease Special Edition | Bixlenvo maintains viral suppression even among patients with preexisting resistance mutations
-
[HIV Glasgow 2026] aidsmap/Life4me+ | A pair of antibodies keeps HIV undetectable – but who would benefit most?
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.